Background and objective: Mitral regurgitation (MR) after myocardial infarction (MI) carries adverse prognosis. The objective of this study was to assess the impact of functional MR on adverse in-hospital outcomes in acute MI.
1.

Introduction
Ischemic mitral regurgitation (MR) after myocardial infarction (MI) is a recognized adverse prognostic factor known to account for increased risk of adverse patient outcomes: it is an independent predictor of increased mortality, risk of heart failure and death at long-term follow-up [1, 2] . Although MR after MI is a frequently reported echocardiographic finding, significant (moderate and severe) MR is less prevalent [3] . Recently even mild MR was recognized as an important risk factor contributing to increased risk of heart failure and death after MI during a long-term follow up [2, 4] .
A great proportion of lethal post MI complications occur in acute phase of myocardial infarction or during the hospitalization period, and the role of ischemic MR in this setting is being explored [1, 5, 6] .
Reported incidence of significant (moderate and severe) MR after MI ranges between 6% and 12% [3, 7, 8] . Recognition of ischemic MR and pitfalls of its estimation by angiographic studies and semi-quantitative color flow Doppler echocardiographic imaging rises a need to reassess the prevalence of ischemic MR by established quantitative doplerographic measures according to recent international guidelines for valve function assessment [9] .
The aims of this study are to assess the incidence of mitral regurgitation in patients with myocardial infarction, to determine associated clinical factors, and the impact of MR on in-hospital cardiac death.
Materials and methods
Retrospective analysis of electronic health records database was performed to identify patients, who presented and were treated for suspected acute myocardial infarction at Hospital of Lithuanian University of Health Sciences (HLUHS) Kaunas clinics in the year 2012: 869 such cases were identified. Only patients with confirmed diagnosis of MI who met the diagnostic criteria of European Society of Cardiology third definition of myocardial infarction [10] and had undergone inhospital departmental echocardiographic examinations were further considered for inclusion in the study (812 cases). The echocardiographic reports were reviewed for adequate data and quality assessment. The following exclusion criteria were applied: reported suboptimal image quality for valve function assessment, structural hemodynamically significant aortic valve disease, structural mitral valve abnormalities, left sided heart valve replacement/repair, mechanical complications of myocardial infarction, known dilated, hypertrophic or storage cardiomyopathies, and previously known mitral regurgitation. Application of aforementioned exclusion criteria resulted in final study population comprising 731 patients with confirmed MI (with or without ST segment elevation on ECG) and adequate departmental echocardiographic assessment of cardiac structures and valve function.
The following clinical data were obtained from medical records: vital parameters (arterial blood pressure and heart rate upon admission), medical history (arterial hypertension, history of prior MI, dyslipidemia, diabetes mellitus, ischemic stroke, and atrial fibrillation), biochemical markers (peak troponin I, peak C-reactive protein (CRP) values, serum creatinine, lipid profile 
Results
The 
Demographic and clinical profile
Basic demographic and clinical characteristics were compared among the three groups of mitral regurgitation in the first ever MI population (n = 569). The findings are presented in Table 2 .
Patients with increasing grade of MR were progressively elder (P < 0.001). Patients in M/S-MR group were more likely to be female (P = 0.003), had lower systolic (P = 0.009) and diastolic blood pressure upon presentation (P = 0.014), higher peak CRP values (P = 0.001), and lower plasma triglyceride levels (P = 0.004) as compared to no MR and M-MR groups. There was no statistically significant difference in these parameters between no-MR and M-MR groups. Dyslipidemia was less likely to be present in M/S-MR group compared to the no-MR group (P = 0.029) while the M-MR group was found to be statistically no different in the prevalence of dyslipidemia from either other MR group. Total cholesterol (P = 0.002) and LDL levels (P = 0.007) were significantly higher in no MR compared to both MR groups (M-MR and M/S-MR). Although proportionately more cases of M/S-MR group fell to the highest troponin rise category than in any other MR subgroup, statistically significant difference is attributable to maximal troponin rise in the moderate range (tertile 2): more cases of no MR group had maximal troponin rise within the moderate range (55.3%) as compared to M/S-MR group (18.4%). There was no statistically significant association found between the presence of MR and arterial hypertension, diabetes, renal failure or history of ischemic stroke; however there was a strong association between moderate and severe mitral regurgitation and history or presence of atrial fibrillation (including both its paroxysmal and chronic forms, P < 0.001). 3.3.
Localization and type of MI
In 11 of the 569 patients, the localization of MI was undefined due to lack of ischemic ECG changes or underlying Hiss bundle branch block, and coronary angiography was inconclusive for the culprit lesion (presence of angiographically significant coronary artery disease in more than one coronary artery territory). The presence and degree of MR was compared among the three groups of MR in 558 remaining patients with identifiable MI localization based on ECG and/or coronary angiography findings (Table 3) . There was no association found between MR grade and presence of pathological Q wave formation or ST segment elevation on ECG (Table 4 ). There were relatively few cases of isolated posterior (n = 17) and lateral (n = 10) MI; therefore, the incidence of MR was compared between anterior and inferior MI groups. M/S-MR was significantly more prevalent in inferior compared to anterior MI group (20.8% vs. 12.1%, P = 0.006), while more cases of mild MR were observed in anterior MI group. There was no impact of cardiac conduction disturbances or permanent cardiac pacing found on the presence of any degree of MR.
3.4.
Angiographic data
All study patients had undergone coronary angiography (Table 5) . Number of coronary vessels with angiographically significant lesions (coronary artery luminal stenosis by visual assessment equal to or greater than 70%) was higher in M/S-MR group compared to the no-MR and M-MR groups (P < 0.001).
Patients in M/S-MR group were more likely to have triple vessel CAD compared to the no-MR and M-MR groups (P = 0.002). Left main coronary artery (LMCA) and right coronary artery (RCA) lesions were found to be strongly associated with the presence of moderate and severe MR (P < 0.001). There was no significant difference in MR grade distribution between successful and unsuccessful/not performed PCI subgroups.
Echocardiographic determinants
A graded association was found between MR grade, LV EDD index, MMI, and EF. Increasing LV EDD dimensions and MMI, and decreasing EF are strongly associated with greater MR (P < 0.001) ( Table 6 ). There was no significant relation of the presence of mitral annular calcification and MR grade. 3.6.
In-hospital outcomes
In-hospital treatment duration did not differ significantly among the groups of MR, although a trend toward longer inhospital stay was observed with increasing MR severity (P = 0.05) ( Table 7 ). Severe heart failure or cardiogenic shock (Killip class 3 and 4) was more prevalent in M/S-MR group compared to no MR and M-MR groups (P < 0.001) ( 
Predictors of mitral regurgitation and its severity
Predictors of MR after myocardial infarction in general MI (n = 731) and incidental MI populations (n = 569) were evaluated using logistic regression analysis. In univariate logistic regression analysis previous MI, female gender, atrial fibrillation, dyslipidemia, heart failure class 3/4 (Killip), RCA and LMS lesions were found to be related to development of MR in incidental MI and general MI populations (Table 8 ). Additional clinical parameters as peak CRP, extent of coronary artery disease have not shown additional predictive value in logistic regression models. Multivariate logistic regression analysis revealed that only age, EF, LVEDD index, and any form of atrial fibrillation are independent predictors of MR severity in acute MI (P < 0.001) ( Table 9 ).
Predictors of in-hospital death in acute MI population
Heart failure class 3-4 (Killip), atrial fibrillation, and moderate and severe MR were predictors of in-hospital cardiac death in univariate regression analysis (Table 10 ). Due to relatively low overall incidence of fatal in-hospital outcomes (16 cases [2.8%] in first-ever MI population) multivariate regression analysis was not applicable to this study.
Discussion
Our study reports the incidence of hemodynamically significant (moderate and severe) functional (ischemic) mitral regurgitation of 17.2%. Reported incidence of significant (moderate and severe) MR after MI in previous large epidemiological studies ranges between 6% and 12% [3, [7] [8] [9] 11] . Majority of previous studies classified MR grade based on semi quantitative color flow Doppler mapping or angiographic criteria, while our study predominately employed quantitative echocardiographic Doppler parameters. Population and community based cohort studies have identified various factors associated with MR in general population: female gender, advanced age, low BMI, renal dysfunction, prior myocardial infarction, arterial hypertension [12, 13] . These and other clinical predictors of MR were as well explored in post-MI setting. Up to date there is uniform agreement on prognostic significance of age, female gender, LV dysfunction, dimensions and volumes in development of MR in post-MI setting [2] . Multiple other clinical factors were suggested to predict development of MR in acute coronary syndromes (ACS): concomitant comorbidities (diabetes, renal 
failure), larger infarct zone, multivessel coronary artery disease (CAD) [10, 12, 14] . This study is in line with many of the previous findings. However, we have identified potentially new factors that may play a role in development of ischemic MR as inflammatory component (CRP rise) and disturbances of lipid profile which should be investigated separately in further studies.
Our study has shown that significant (moderate and severe) MR is more prevalent in the inferior MI group. Reports on whether the left ventricular (LV) infarction localization is a risk factor for MR severity differ: the incidence of ischemic MR has been reported to be higher in inferior compared to anterior MI localization [1, 6, 15] ; however, the difference in incidence of moderate or severe MR based on MI localization was reported as insignificant by other author teams [3, 12] .
Ischemic mitral regurgitation and functional mitral regurgitation in general terms share important associated clinical determinants (older age, female gender) [12, 13] . It is reasonable to expect some overlap between these two clinical entities, however incidence and prevalence of significant MR is much higher in MI population or patients with prior MI, indicating important role of myocardial ischemia and LV remodeling [5, 6] . Important role of LV remodeling is further supported by identifiable predictors of ischemic MR, confirmed and consistent with minor variations throughout the published studies and our results: extent of CAD, previous MI, larger LV dimensions and volumes, and decreased LV systolic function [2, 3, 11, 12, 15] . Significant MR is strongly associated with advanced age in MI and general population, therefore factors associated with ageing (varying degree of mitral annular calcification, long-standing arterial hypertension, comorbidities) need to be considered. Some of these clinical criteria have been previously addressed in the context of MR post MI (e.g. arterial hypertension, renal failure), and the results are diverging [16] . We have addressed the issue of mitral annular calcification (MAC), which is reported to be associated with ageing and MR [17] . Although in patients with MR MAC was reported relatively more often, the difference was not significant compared to patients with no MR, and MAC did not have any predictive value on development of significant (moderate and severe) MR in acute MI setting.
The relation of female gender to the presence of MR is reported in great extent [2] . Although female to male ratio was higher in moderate and severe MR group, our study has shown no impact of gender in predicting development of MR or inhospital cardiac death when adjusted to other confounding factors. Age, EF, LVEDDi, and atrial fibrillation (AF) were found to independently predict development of significant MR in multivariate regression analysis. Our study reports the prevalence of atrial fibrillation (AF) in incidental acute MI population of 11.8%, which corresponds to the reported rates of this arrhythmia in the literature [18] . However AF can be a causative or consecutive factor of either MI or MR, and preexistent silent AF is always a possibility. Any form of AF was found to be highly related to moderate and severe MR, and an independent predictor of significant MR in multivariate regression analysis.
Mitral regurgitation is reported to account for higher mortality rates in long-term follow-up [2] . Our study was aimed to assess and emphasize the impact of MR on short term (in-hospital) survival. Moderate and severe MR is strongly associated with in-hospital cardiac death, when considered separately from other clinical factors. Mild MR in acute inhospital MI setting is not a significant prognostic factor of adverse events. This finding suggests the possibility of more important predictive role of mild MR to long-term follow-up outcomes, which is increasingly reported in the literature [3] [4] [5] 8, 11, 12, 18] .
Study limitations
The major study limitation is the retrospective design, which disabled us from active control of clinical factors and outcome assessment, consequently adequacy of medical records was relied on. We acknowledge that selection bias may have affected the study cohort; however exclusion of cases as per applied criteria (unconfirmed MI, organic left sided heart valve disease or long-standing significant MR, inadequate echocardiographic imaging quality, etc.) was needed to prevent greater bias in identifying truly ischemic MR cases. Additionally, misclassification of study participants as the first incidental MI group was possible, as despite absence of previous history of ischemic heart disease, prior silent MI is a possibility in a proportion of patients with significant multivessel coronary artery disease. The latter limitation is applicable to all epidemiological studies of ischemic MR. Furthermore, interobserver variability may account for misclassification of MR cases according to severity, however all echocardiographic scans are solely performed and reported by experienced cardiologists at HLUHS Kaunas Clinics and international guidelines are adhered to while grading valvular heart disease. Finally, retrospective study design precluded us from being able to assess the impact of timing factor from symptom onset to coronary artery reperfusion therapy in development of ischemic MR.
Conclusions
Functional mitral regurgitation in acute phase of myocardial infarction is prevalent. The major clinical associates are advanced age, atrial fibrillation, increased LV diastolic dimensions and lower EF. Moderate and severe, but not mild MR is an important clinical associate with in-hospital cardiac death.
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